FDA recalls over 89K bottles of nasal spray that may cause ‘adverse’ medical effects during flu season, throw out ASAP
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
Mucus in nose and throat: How to stop post-nasal drip at home
Post-nasal drip occurs when excess mucus accumulates in the back of the throat or nose, primarily due to allergies, ...
Allergies vs Cold Symptoms: How to Determine What’s Making You Miserable
Aches and pains. Pain (think: body aches and a sore throat) is also a tip off that you’re dealing with a virus like a cold.
GlobalData on MSN2d
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
cnbctv182d
Lupin secures US FDA approval for generic version of Atrovent nasal spray
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
Lupin gets USFDA approval for nasal spray; share price trade lower
A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...
Irish Examiner on MSN6d
Nasal irrigation: Breathe easy by flushing out your nasal cavity
Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Stocks to Watch: Nykaa, Grasim Industries, Eicher Motors, Lupin, NALCO, and more
Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...
Rolling Out2d
The surprising side effect Ozempic users never expected
As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.
Keymed Biosciences Inc.: Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...